Read More Pharma Industry News AstraZeneca, Daiichi Sankyo’s Enhertu approved for breast cancer in China The National Medical Products Administration (NMPA) of China has granted approval to AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab… byPallavi MadhirajuJuly 15, 2023